from the Blog Innovations in Continuous Glucose Monitoring (CGM) & How BDK Can Help

Continuous Glucose Monitoring (CGM) has revolutionised diabetes management over the last decade, empowering individuals to track their glucose levels seamlessly. This article delves into the latest innovations in CGM and highlights how BDK is at the forefront of supporting these advancements.

The Landscape of Continuous Glucose Monitoring

1 in 15 of us is now living with diabetes and this number is set to continue rising, so the evolution of CGM is crucial.

At present, CGMs use small needle sensors that penetrate the skin’s dermis layer, providing real-time blood glucose readings displayed on a reader or a connected smart device.

Non-Invasive Glucose Monitoring

One of the most anticipated innovations in continuous glucose monitoring is a non-invasive solution. This technology would enable diabetics to remove the need of consumables and rely on a wearable device instead, which would only require software updates.

Proposed technology involves the use of infrared lasers that penetrating the skin’s dermis layer to analyse underlying tissue and glucose concentration.

Closed Loop Systems

While hybrid closed loop systems are already available, ongoing research aims at developing a fully closed loop system, minimising manual input. These systems link with algorithms to determine insulin requirements.

This will enable diabetics to have access to real-time data for enhanced blood glucose management and reduced hypoglycaemic incidents. Additionally, advancements in delivering the hormone ‘glucagon’ through closed loop systems are being explored.

Continuous Ketone Monitoring (CKM)

Ketones are produced by our liver when fats are broken down and are used when carbohydrates are unavailable in order to provide energy. Although a natural response, having increased levels of these chemicals for those who use insulin puts them at risk of diabetic ketoacidosis (DKA).

In order to protect diabetics against DKA, research is going into developing sensors similar to those used in blood glucose testing to create continuous ketone monitoring (CKM). There is much more work needed to refine the parameters and to make sure the technology is integrated safely and effectively, but these advancements are promising.

As a leading healthcare and medical convertor and with innovation embedded in our core, BDK supports new technologies to enhance patient care and empower healthcare organisations in their developments. Our adhesive solutions and versatile capabilities adapt seamlessly to the ever evolving landscape of wearable technologies, including CGMs. We take pride in providing cutting edge solutions, now and in the future.

If you’d like to talk to us about new or future opportunities, please get in touch here.